European Journal of Chemistry

Synthesis, configuration and properties of some new 3,4,5-substituted oxazolidin-2-ones



Main Article Content

Anelia Tsenova Mavrova
Pavletta Stoyanova Denkova
Jordan Andreev Tsenov

Abstract

Novel 3,4,5-substituted-oxazolidin-2-ones containing piperazine, 1-(4-chlorophenyl) piperazine, benzhydrylpiperazine, morpholine and piperidine rings were synthesized via Mannich reaction. The stereochemistry of syn and anti-isomers was assigned using the observed differences in the chemical shifts of the oxazolidinone ring protons and the values of vicinal coupling constants (3J) between the two protons of the oxazolidin-2-one ring. For all compounds NOE (Nuclear Overhauser Effect) NMR spectra were measured in order to prove additionally the position of the substituents in the oxazolidin-2-one ring. Some physic chemical, steric and electronic properties of the compounds were determined in order to establish the similarity between the synthesized and reference compounds. The performed computations showed that the anti-isomers possessed lower electronic energies in comparison to these of syn-compounds. The nucleus-nucleus repulse energies (NRE) and the highest occupied molecular orbital energies (HOMO) of the anti-isomers are higher than the HOMO and NRE energies of syn-compounds. The Connolly Solvent Accessible Surface Area (SAS) and Connolly Molecular Surface Area (MS) values of anti-isomers are lower than these of syn-isomers. The same relations were observed for the reference compounds. Probably the differences in the electronic and steric properties are responsible not only for the higher LD50 value of the reference anti-compound, but also may contribute to the higher toxicity of the prepared anti-Mannich bases in comparison to that of the syn-diastereoisomers.

2_1_18_24_800


icon graph This Abstract was viewed 1083 times | icon graph Article PDF downloaded 646 times

How to Cite
(1)
Mavrova, A. T.; Denkova, P. S.; Tsenov, J. A. Synthesis, Configuration and Properties of Some New 3,4,5-Substituted Oxazolidin-2-Ones. Eur. J. Chem. 2011, 2, 18-24.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Narasaka, K. Pure and Appl. Chem. 1992, 64 (12), 1889-1896.
doi:10.1351/pac199264121889

[2]. Dixon, D. J.; Horan, R. A.; Monck, N. J; Berg, P. Org. Lett. 2004, 6(24), 4427-4429.
doi:10.1021/ol048568q
PMid:15548042

[3]. Palomo, C.; Oiarbide, M.; Garcia, J. M. Chem. Eur. J. 2002, 8, 36-44.
doi:10.1002/1521-3765(20020104)8:1<36::AID-CHEM36>3.0.CO;2-L

[4]. Davies, S. G.; Garner A. C.; Roberts P, M.; Smith A. D; Sweet M. J; Thomson J. E. Org. Biomol. Chem. 2006, 4(14), 2753-2768.
doi:10.1039/b604073j

[5]. SeoW, D.; Curtis-Long J.; Kim, J. H.; Park, J. K.; Park, K. M.; Park K. H. Synlett. 2005, 15, 2289-2292.

[6]. Ammazzalorso, A.; Amoroso, R.; Bettoni, G.; Fantacuzzi, M.; De Filippis, B.; Giampietro, L.; Maccallini, C.; Paludi, D.; Tricca, M. L. II Farmaco 2004, 59 (9), 685-690.
doi:10.1016/j.farmac.2004.05.002
PMid:15337433

[7]. Jang S. Y.; Ha Y. H.; Ko S. W.; Lee W.; Lee J.; Kim S; Kim Y. W; Lee W. K.; Ha H. J. Bioorg& Med Chem Lett. 2004, 14(15), 3881-3883.
doi:10.1016/j.bmcl.2004.05.066

[8]. Mishra, R. K.; Revell, K. D.; Coates C. M.; Turos, E.; Dickey, S.; Lim, D. V. Bioor & Med. Chem. Letts, 2006, 16(8), 2081-2083.
doi:10.1016/j.bmcl.2006.01.058

[9]. Zappia, G.; Menendez, P.; Giuliano, D. M.; Misiti, D.; Nevola, L.; Botta, B. Mini Rev. Med. Chem. 2007, 7(4), 389-409.
doi:10.2174/138955707780363783
PMid:17430225

[10]. Mai, A.; Artico M.; Valente, S.; Sbardella, G.; Befani, O.; Turini, P.; Befani, O.; Vedova L. D.; Agostinelli, E.; Med. Chem. 2005, 1(2), 117-124.
PMid:16787307

[11]. Lamanna, C.; Sinicropi, M. S.; Pietrangeli, P.; Corbo, F.; Franchini, C.; Mondovì, B.; Perrone, M. G.; Scilimati A. Arkivoc, 2004, 5, 118-130.

[12]. Mai, A.; Artico, M.; Valente, S.; Cerbara, I.; Befani, O.; Turini, P.; Vedova, L. D.; Agostinelli E. Arkivoc, 2004, 5, 32-43.

[13]. Pallavicini, M.; Moroni. B.; Bolchi, C.; Cilia, A.; Clementi, F.; Fumagalli, L.; Gottib, C.; Meneghetti, F.; Riganti, L.; Vistoli, G.; Valoti, E. Bioor & Med. Chem. Lett. 2006, 16(21), 5610-5615.
doi:10.1016/j.bmcl.2006.08.020

[14]. Tatsumi, R.; Fujio, M.; Takanashi, S.; Numata, A.; Katayama, J.; Satoh, H.; Shiigi, Y.; Maeda, J.; Kuriyama, M.; Horikawa, T.; Murozono, T.; Hashimoto, K.; Tanaka, H. J. Med. Chem. 2006, 49(14), 4374-4383.
doi:10.1021/jm060249c
PMid:16821797

[15]. Hobbs, S. H., Johnson, S. J. US patent, 1991, No 5066662.

[16]. Mavrova, A.; Natova, L.; Zhelyaskov, L.; Stefanova, D. Bg patent, 1988, No 43923, (C07D263/20, A61K31/42).

[17]. Wardakhan, W. W.; Abdel-Salam O. M; Elmegeed G. A. Acta Pharm. 2008, 58(1), 1–14.
doi:10.2478/v10007-007-0041-5
PMid:18337204

[18]. Sondhi, Sh. M.; Jain, Sh.; Dinodia, M.; Kumar, A. Med. Chem. 2008, 4(2), 146-154.
doi:10.2174/157340608783789194
PMid:18336334

[19]. Molvi Kh. I.; Mansuri, M.; Sudarsanam, V.; Patel, M. M.; Andrabi, S. M. A. Haque N. J. Enz. Inhib. Med. Chem. 2008, 23 (6), 829- 838.
doi:10.1080/14756360701626082
PMid:18618323

[20]. Ranise, A.; Spallarossa, A.; Bruno, O.; Schenone S.; Fossa, P.; Menozzi, G.; Bondavalli, F.; Mosti, L.; Capuano, A.; Mazzeo, F.; Falcone, G.; Filippelli, W. Il Farmaco, 2003, 58(9), 765-780.
doi:10.1016/S0014-827X(03)00132-0

[21]. G. Zappia, G., Gacs-Baitz, E.; Delle Monache; D. Misiti, D.; Nevola, L.; Botta, B. Curr. Org. Synt. 2007, 4, 81-135.
doi:10.2174/157017907779981552

[22]. Mavrova, A., Wesselinova, D. Compt. Rend. Acad. Bulg. Sci. 2003, 55(7), 59-64.

[23]. Chem3D Ultra, Molecular modeling and analyses, Version 11. 0. 1, CambridgeSoft Corporation, Cambridge.

[24]. Günther H. NMR spectroscopy: Basic Principles, Concepts and Applications in Chemistry, Wiley, Chichester, England, 1995.

[25]. Pretsch E., Clerc J. T. Spectra Interpretation of Organic Compounds, Weinheim, Germany, VCH, 1997.

[26]. Neuhaus, D.; Williamson, M. The Nuclear Overhauser Effect in Structural and Conformational Analysis, Wiley–VCH: New York, 2000.

[27]. Nikolova, N., Javorska, J. QSAR Comb Sci. 2003, 22, 1006-1026.
doi:10.1002/qsar.200330831

[28]. Karelson, M.; Lobanov V. S.; Katritzky, A. R. Chem. Rev. 1996, 96, 1027-1044.
doi:10.1021/cr950202r
PMid:11848779

[29]. Bijev, A., Yaneva, D., Bocheva, A. Arzneimittel-Forsch. 2006, 56(11), 753-759.
PMid:17220053

Supporting Agencies

Thanks are due to National Science Fund/Ministry of Education and Science grant X1408 and Science Fund/Chemical Technology and Metallurgy University grant 10580 for the financial support of this work.
Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).